Scientists search for genetic clues to improve cancer treatment
NCT ID NCT01827956
Summary
This study aimed to understand if a person's genetics can predict how well the drug cetuximab works for treating advanced head and neck cancers. Researchers collected blood samples from 121 patients with recurrent or metastatic cancer to analyze specific genes. The goal was to find a genetic marker that could help doctors know in advance which patients are most likely to benefit from this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UPPER GINGIVAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Bergonié
Bordeaux, Aquitaine, 33000, France
Conditions
Explore the condition pages connected to this study.